Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective

Официальное название

Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective - A Quasi Experimental Study

Обзор

This study aims to evaluate the impact of using a mobile application-based medication reminder on medication adherence among patients diagnosed with chronic diseases and memory impairment. Adherence to prescribed therapy is a significant challenge for this patient population, often leading to poor health outcomes and increased healthcare costs. From a nursing leadership perspective, innovative digital solutions can play a crucial role in supporting patient self-management. Using a quasi-experimental design, the study will investigate whether a customized mobile reminder system can effectively improve adherence rates and support patients in managing their therapeutic regimens.

Подробное описание

Improving medication adherence in patients with chronic illnesses and cognitive decline is a key priority in healthcare management and nursing administration. This quasi-experimental study utilizes a pretest-posttest design to examine the effectiveness of a mobile application-based reminder system designed specifically for patients experiencing memory impairment.

Participants will be selected based on specific inclusion criteria, including being diagnosed with a chronic disease and exhibiting mild-to-moderate memory impairment. Baseline assessments (pretest) will be conducted to measure initial medication adherence levels, patient demographics, and health status. Following the baseline phase, the intervention will be introduced, where participants will utilize the mobile application to receive automated medication alerts and reminders over a specified period. Evaluation (posttest) will be performed post-intervention to analyze changes in adherence rates. The findings are expected to provide insights into how nursing leadership can leverage mobile health (mHealth) technology to design supportive care pathways, enhance patient independence, and reduce clinical complications associated with poor treatment adherence.

Вмешательства

• Устройство Mobile Application-Based Medication Reminder
  The intervention consists of a mobile application specifically designed to support medication adherence. It features automated push notifications, customized reminder alerts matching prescribed medication schedules, and tracking logs. Participants will be instructed on how to install, configure, and use the application on their personal smartphones. The system is designed to provide immediate prompts to overcome memory-related adherence barriers.

Первичные конечные точки

• Medication Adherence (MMAS-8) [Срок оценки: Baseline (pre-intervention) and 3 months post-intervention]

Вторичные конечные точки (4)

• Objective Medication Adherence: Medication Possession Ratio (MPR) [Срок оценки: 3 months post-intervention]
• Objective Medication Adherence: Proportion of Days Covered (PDC) [Срок оценки: 3 months post-intervention]
• Cognitive Function Status (MMSE) [Срок оценки: Baseline]
• Perceived Nursing Care and Leadership Support [Срок оценки: 3 months post-intervention.]

Критерии участия

Критерии включения

• Patients diagnosed with one or more chronic diseases requiring regular long-term medication.
• Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE).
• Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application.
• Patients aged 18 years and older.
• Patients who provide voluntary informed consent to participate in the study.

Критерии исключения

• Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance.
• Patients with severe acute clinical complications or unstable psychiatric conditions.
• Patients participating in another concurrent clinical trial or study targeting medication adherence

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Не применимо

Модель

Одна группа

Маскирование

Открытое

Основная цель

Поддерживающая терапия

Центры проведения

Египет · 2 центра

• Outpatient Clinics, Delta University for Science and Technology — Gamasa
• Outpatient Clinics, Kafr El-Sheikh Hospital — Kafr ash Shaykh

Идентификаторы

NCT: NCT07718334 · DFM-IRB 00012367- 26-04-001

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗